First Analysis invests in 4G Clinical

First Analysis has made an investment in Wellesley, Massachusetts-based 4G Clinical, a provider of randomization and trial supply management solutions for the life sciences industry.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this